Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB4 known ✓ | P30926 | 1/20 | 0.46 |
| ▸ | CHRNA3 known ✓ | P32297 | 1/20 | 0.46 |
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.43 |
| ▸ | HNF4A | P41235 | 1/20 | 0.63 |
| ▸ | FABP3 | P05413 | 1/20 | 0.53 |
| ▸ | FABP4 | P15090 | 1/20 | 0.53 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.53 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.53 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | CDC25B | P30305 | 2/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | MYC | P01106 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL628183 | 1.00 | HNF4A (0.63) | HNF4AFABP3FABP4FABP5FOLH1 | |
| SCHEMBL29376910 | 0.98 | HNF4A (0.66) | HNF4AFABP3FABP4FABP5FOLH1 | |
| SCHEMBL36146 | 0.98 | HNF4A (0.66) | HNF4AFABP3FABP4FABP5FOLH1 | |
| SCHEMBL28558290 | 0.96 | HNF4A (0.63) | HNF4AFABP3FABP4FABP5FOLH1 | |
| SCHEMBL6666734 | 0.96 | HNF4A (0.63) | HNF4AFABP3FABP4FABP5FOLH1 | |
| SCHEMBL2833055 | 0.96 | HNF4A (0.63) | HNF4AFABP3FABP4FABP5FOLH1 | |
| SCHEMBL6661257 | 0.96 | HNF4A (0.63) | HNF4AFABP3FABP4FABP5FOLH1 | |
| SCHEMBL6662914 | 0.96 | HNF4A (0.63) | HNF4AFABP3FABP4FABP5FOLH1 | |
| Methane SCHEMBL28932446 | 0.96 | HNF4A (0.63) | HNF4AFABP3FABP4FABP5FOLH1 | |
| Bromide SCHEMBL8757513 | 0.96 | HNF4A (0.63) | HNF4AFABP3FABP4FABP5FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 319 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122080606-A | Allyl polyarylester modified bismaleimide resin and preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122080404-A | Copolyamide imide, film, preparation method and electronic device | — | 2026-05-26 | — | — | CN | claimed |
| CN-122080343-A | Method for synthesizing polyarylketone compound | — | 2026-05-26 | — | — | CN | claimed |
| US-20260054227-A1 | COMPOSITE MEMBRANE AND METHOD OF MAKING THE SAME | H2MO TECH PTE LTD (SG) | 2026-02-26 | — | — | US | claimed |
| US-12485388-B2 | Composite membrane and method of making the same | H2MO TECHNOLOGY PTE LTD (SG) | 2025-12-02 | — | — | US | claimed |
| CN-120005178-A | Method for producing polyamide polymer, polyamide nanoparticle, method for producing reverse osmosis membrane, and reverse osmosis membrane produced by using same | 沃顿科技股份有限公司 | 2025-05-16 | — | — | CN | claimed |
| CN-119746656-A | Preparation method of positively charged nanofiltration membrane, nanofiltration membrane and application of nanofiltration membrane | 东莞市创明电池技术有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-119565382-A | Method for cleaning reverse osmosis membrane and reverse osmosis membrane prepared by same | 万华化学集团股份有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-115845615-B | High-flux polyethylene-based reverse osmosis membrane and preparation method and application thereof | 万华化学集团股份有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119345927-A | Polyamide composite semipermeable membrane and preparation method and application thereof | 万华化学集团股份有限公司 | 2025-01-24 | — | — | CN | claimed |
| WO-2022058961-A1 | MOLECULARLY POROUS CROSS-LINKED MEMBRANES | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2022-03-24 | — | — | WO | claimed |
| CN-114053876-A | Preparation method of anti-pollution reverse osmosis membrane | 万华化学集团股份有限公司 | 2022-02-18 | — | — | CN | claimed |
| CN-113600040-A | High-flux polyethylene-based reverse osmosis membrane and preparation method and application thereof | 万华化学集团股份有限公司 | 2021-11-05 | — | — | CN | claimed |
| WO-2021201783-A1 | A COMPOSITE MEMBRANE AND METHOD OF MAKING THE SAME | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2021-10-07 | — | — | WO | claimed |
| CN-112827368-A | Anti-pollution reverse osmosis membrane and preparation method thereof | 中化(宁波)润沃膜科技有限公司 | 2021-05-25 | — | — | CN | claimed |
| US-20160263530-A1 | FABRICATION AND MODIFICATION OF POLYMER MEMBRANES USING INK-JET PRINTING | B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD (IL) | 2016-09-15 | — | — | US | claimed |
| EP-1020218-B1 | COMPOSITE REVERSE OSMOSIS MEMBRANE AND PROCESS FOR PREPARING THE SAME | NITTO DENKO CORP (JP) | 2003-05-21 | — | — | EP | claimed |
| EP-1020218-A1 | COMPOSITE REVERSE OSMOSIS MEMBRANE AND PROCESS FOR PREPARING THE SAME | NITTO DENKO CORPORATION (JP) | 2000-07-19 | — | — | EP | claimed |
| EP-0517943-A1 | Copolyestercarbonate polymers derived from diaryl dicarboxylic acids and their derivatives and blends thereof | THE DOW CHEMICAL COMPANY (US) | 1992-12-16 | — | — | EP | claimed |
| US-5045610-A | Thermoplastic Molding Materials | THE DOW CHEMICAL COMPANY (US) | 1991-09-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260054227-A1 | COMPOSITE MEMBRANE AND METHOD OF MAKING THE SAME | AQP1, AQP4, AQP3 | CHRNB4 3363/4885CHRNA3 3318/4885CA2 1281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.